Clinical Rheumatology

, Volume 24, Issue 1, pp 48–54 | Cite as

Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms

  • Elisabetta Danieli
  • Paolo AiròEmail author
  • Lorenzo Bettoni
  • Massimo Cinquini
  • Chiara M. Antonioli
  • Ilaria Cavazzana
  • Franco Franceschini
  • Roberto Cattaneo
Original Article


The aim of this study was to evaluate health-related quality of life (HR-QOL) in patients with systemic sclerosis (SSc), to compare it with that of patients with rheumatoid arthritis (RA), and to correlate it with other parameters. HR-QOL was evaluated by the Short Form 36 (SF-36), SSc disease activity and severity by preliminary indexes recently proposed, disability by the Health Assessment Questionnaire (HAQ), and depressive symptoms by the Beck Depression Inventory. HR-QOL perception was not statistically different in patients with SSc and RA, except that patients with diffuse cutaneous involvement had worse scores in the general health and mental health dimensions than patients with RA (p=0.03). Compared with RA, patients with SSc tended to perceive less bodily pain (p=0.06) and have less disability (p=0.04) but to report higher depressive symptom scores (p=0.05). SSc patients’ HR-QOL was associated with some disease severity scales (general, kidney and, less significantly, heart), but it was poorly correlated with the other evaluated disease activity and severity indexes. A strong correlation with disability and with depressive symptoms was observed. In conclusion, patients with SSc perceived a reduced HR-QOL similar to that of patients with RA. SF-36 may provide useful information in their evaluation.


Depression Disease activity Disease severity HAQ SF-36 Systemic sclerosis 



Health Assessment Questionnaire


Beck Depression Inventory


  1. 1.
    Haythornthwaite JA, Heinberg LJ, McGuire L (2003) Psychological factors in scleroderma. Rheum Dis Clin North Am 29:427–439PubMedCrossRefGoogle Scholar
  2. 2.
    Calkins DR, Rubenstein LV, Cleary PD, et al. (1991) Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med 114:451–454PubMedCrossRefGoogle Scholar
  3. 3.
    Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRefGoogle Scholar
  4. 4.
    Brazier JE, Harper R, Jones MB, et al. (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160–164PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Mc Horney CA, Ware JE, Lu JFR (1994) The MOS 36-item short-form health survey (SF-36). III. Tests of data quality, scaling assumptions and reliability across diverse patient groups. Med Care 32:40–66CrossRefGoogle Scholar
  6. 6.
    Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russel IT (1993) The SF-36 Health Survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 306:1440–1444PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Talamo J, Frater A, Gallivan S, Young A (1997) Use of the short-form (SF-36) for health status measurement in rheumatoid arthritis. Br J Rheumatol 36:463–469PubMedCrossRefGoogle Scholar
  8. 8.
    Husted JA, Gladman DD, Farewell VT, Long JA, Cook RJ (1997) Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 24:511–517PubMedGoogle Scholar
  9. 9.
    DaCosta D, Dobkin PL, Fitzcharles MA, et al. (2000) Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. J Rheumatol 27:365–372Google Scholar
  10. 10.
    Ruta DA, Hursat MP, Kind P, Hunter M, Shibbings A (1998) Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the Short-Form 36-item health survey (SF-36). Br J Rheumatol 37:425–436PubMedCrossRefGoogle Scholar
  11. 11.
    Kvien TK, Kaasa S, Smedstad LM (1998) Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 51:1077–1086PubMedCrossRefGoogle Scholar
  12. 12.
    Hill CL, Parsons J, Taylor A, Leach G (1999) Health related quality of life in a population sample with arthritis. J Rheumatol 26:2029–2035PubMedGoogle Scholar
  13. 13.
    Strombeck B, Ekdahl C, Manthorpe R, Wilkstrom I, Jacibsson L (2000) Health-related quality of life in primary Sjögren’s syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 29:20–28PubMedCrossRefGoogle Scholar
  14. 14.
    Husted JA, Gladman DD, Farewell VT, Cook RJ (2001) Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 45:151–158PubMedCrossRefGoogle Scholar
  15. 15.
    Wiles NJ, Scott DGI, Barrett EM, et al. (2001) Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire: and the short-form (SF-36) in a community and a clinic based sample. Ann Rheum Dis 60:956–961PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Suarez-Alzamor ME, Ahn C, Friedman AW, et al. (2000) Performance of outcome measures in systemic sclerosis (abstract). Arthritis Rheum 43:S319Google Scholar
  17. 17.
    Grove ML, Wilson A, Raza K, Carruthers DM, Bacon P (2000) Patients with damage from primary systemic vasculitides experience impaired physical health as measured by the SF-36 (abstract). Arthritis Rheum 43:S368Google Scholar
  18. 18.
    Cossutta R, Zeni S, Soldi A, Colombelli P, Belotti Masserini A, Fantini F (2002) Evaluation of quality of life in patients with systemic sclerosis by the SF-36 questionnaire (in Italian). Reumatismo 54:122–127PubMedGoogle Scholar
  19. 19.
    Subcommittee for Scleroderma Criteria of the American Rheumatism Association diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 23:581–590CrossRefGoogle Scholar
  20. 20.
    Arnett FC, Edworthy SM, Block DA, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRefGoogle Scholar
  21. 21.
    LeRoy EC, Black C, Fleischmayer R, et al. (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–208PubMedGoogle Scholar
  22. 22.
    Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51:1025–1036PubMedCrossRefGoogle Scholar
  23. 23.
    Steen VD, Mesdger TA Jr (1997) The value of the Health Assessment Questionnaire and special patient-generated scale to demonstrate change in systemic sclerosis over time. Arthritis Rheum 40:1984–1991PubMedCrossRefGoogle Scholar
  24. 24.
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:53–63CrossRefGoogle Scholar
  25. 25.
    Mesdger TA Jr, Silman AJ, Steen VD, et al. (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159–2167Google Scholar
  26. 26.
    Valentini G, Della Rossa A, Bombardieri S, et al. (2001) European multicentre study to define activity criteria for systemic sclerosis. II Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60:592–598PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    van der Heijde DM, van’t Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van LeeuwenMA, et al. (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49:916–920CrossRefGoogle Scholar
  28. 28.
    Bettoni L, Geri P, Airò P, et al. (2002) Systemic sclerosis therapy with Iloprost. A prospective observational study of 30 patients treated for a median of 3 years. Clin Rheumatol 21:244–250PubMedCrossRefGoogle Scholar
  29. 29.
    Merkel PA, Herlyn K, Martin RW, et al. (2002) Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon. Arthritis Rheum 46:2410–2420PubMedCrossRefGoogle Scholar
  30. 30.
    Clements PJ, Wong WK, Hurwitz EL, et al. (1999) Correlates of the Disability Index of the Health Assessment Questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum 42:2372–2380PubMedCrossRefGoogle Scholar
  31. 31.
    Clements PJ, Wong WK, Hurwitz EL, et al. (2001) The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 44:653–661PubMedCrossRefGoogle Scholar
  32. 32.
    Roca RP, Wigley FM, White B (1996) Depressive symptoms associated with scleroderma. Arthritis Rheum 39:1035–1040PubMedCrossRefGoogle Scholar
  33. 33.
    Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, et al. (2002) The impact of pain and symptoms of depression in scleroderma. Pain 95:267–275PubMedCrossRefGoogle Scholar
  34. 34.
    Newman S, Mulligan K (2000) The psychology of rheumatic diseases. Baillieres Clin Rheumatol 14:773–786CrossRefGoogle Scholar
  35. 35.
    Moser DK, Clements PJ, Brecht ML, Weiner SR (1993) Predictors of psychosocial adjustment in systemic sclerosis. The influence of formal education level, functional ability, hardness, uncertainty, and social support. Arthritis Rheum 36:1398–1405PubMedCrossRefGoogle Scholar
  36. 36.
    Benrud-Larson LM, Heinberg LJ, Haythornthwaite JA, et al. (2002) Body image dissatisfaction in scleroderma: extent and relationship to psychosocial function. Health Psychol 22:130–139CrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2004

Authors and Affiliations

  • Elisabetta Danieli
    • 1
  • Paolo Airò
    • 1
    Email author
  • Lorenzo Bettoni
    • 1
  • Massimo Cinquini
    • 1
  • Chiara M. Antonioli
    • 1
  • Ilaria Cavazzana
    • 1
  • Franco Franceschini
    • 1
  • Roberto Cattaneo
    • 1
  1. 1.Department of Rheumatology and Clinical ImmunologySpedali CiviliBresciaItaly

Personalised recommendations